Triglycidyl isocyanurate
Triglycidyl isocyanurate (TGIC; Teroxirone) is a triazene triepoxide with antiangiogenic and antineoplastic activities. Triglycidyl isocyanurate inhibits the growth of non-small-cell-lung cancer cells via p53 activation. Triglycidyl isocyanurate induces cell apoptosis. Triglycidyl isocyanurate can be used for cancer research[1][2].
Product Specifications
CAS Number
2451-62-9
Product Name Alternative
TGIC
UNSPSC
12352005
Hazard Statement
H301+H331, H317, H318, H340, H412
Target
Apoptosis; MDM-2/p53
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/triglycidyl-isocyanurate.html
Purity
99.56
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(N(C1=O)CC2CO2)N(C(N1CC3CO3)=O)CC4CO4
Molecular Formula
C12H15N3O6
Molecular Weight
297.26
Precautions
H301+H331, H317, H318, H340, H412
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD31 / PECAM-1 (158-2B3), CF640R conjugate, 0.1mg/mL
TNF alpha (J2D10), CF640R conjugate, 0.1mg/mL
Calgranulin B / MRP-8/-14 / MAC 387 / S100A8/A9 / Macrophage Ag (MAC387), CF594 conjugate, 0.1mg/mL
Progesterone Receptor (PR501), CF405S conjugate, 0.1mg/mL
